Navigation Links
Hemophilia Pipeline Overview - Once-a-week prophylaxis may soon become a reality
Date:12/13/2012

recombinant PEGylated factor IX; Baxter)

CSL654 (rFIX-albumin fusion; CSL Behring)

BIIB 029 (rFIXFc; Biogen Idec)

NN7999 (rFIX, glycoPEGylated; Novo Nordisk)

Clinical and commercial attractiveness for key hemophilia B pipeline products

Bibliography

Journal articles and online sources

Appendix

Methodology

Datamonitor drug assessment for clinical and commercial attractiveness

TABLES

Table: Clinical pipeline key drugs for hemophilia A and B, November 2012

Table: Kogenate FS (recombinant Factor VIII; Bayer) – drug profile, 2012

Table: Kogenate FS (recombinant Factor VIII; Bayer) – drug profile, 2012

Table: Kogenate FS (rFVIII; Bayer) and BeneFIX (rFIX; Pfizer) vs the target product profile in previously treated patients, 2012

Table: Key events in the clinical development of NN7008 (turoctocog alfa; Novo Nordisk), 2012

Table: Key events in the clinical development of BIIB 031 (rFVIIIFc; Biogen Idec), 2012

Table: Key events for the clinical development of NN7088 (Novo Nordisk), 2012

Table: Key events for the clinical development of BAY-94-9027 (Bayer), 2012

Table: Key events for the clinical development of BAX 326 (Baxter), 2012

Table: Key events for the clinical development of CSL654 (CSL Behring), 2012

Table: Key events for the clinical development of BIIB 029 (rFIXFc; Biogen Idec), 2012

Table: Key events for the clinical development of NN7999 (Novo Nordisk), 2012

FIGURES

Figure: Clinical and commercial attractiveness for key hemophilia A pipeline drugs vs comparator Kogenate FS (rFVIII; Bayer), 2012

Figure: Breakdown of clinical and commercial attractiveness attributes for key hemophilia A pipeline drugs, 2012

Figure: Launch timeline for key hemophilia A pipeline drugs, 2012

Figure: Clinical and commercial attractiveness for key hemophilia B pipeline drugs vs comparator B
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novo Nordisk introduces HemaGo, a mobile application to track hemophilia treatment, bleeding episodes and life events
2. Bayers Second Annual Virtual Walk for Hemophilia Raises Funds, Generates Excitement in the Hemophilia Community
3. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
4. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
5. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
6. Bausch + Lomb Product, Platform and Pipeline Innovations on Display at the Annual Meeting of the American Academy of Ophthalmology
7. Chronic Heart Failure (CHF) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
8. Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
9. Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
10. Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
11. Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015 Qiming Venture Partners, today announces ... Partner effective immediately. William has been with ... participated in many Qiming healthcare deals, and assisted many ... market. Qiming, s success in healthcare is not a ... himself with his outstanding advocacy and service mentality on ...
(Date:7/1/2015)... Research and Markets( ... "Future Horizons and Growth Strategies in the ... Country Forecasts" report to their offering. ... European Blood Banking Market 2015 is a new ... suppliers and potential market entrants identify and evaluate ...
(Date:7/1/2015)... , July 1, 2015 Rock Creek Pharmaceuticals, ... focused on chronic inflammatory disease and neurologic disorders, announced ... study with anatabine citrate, the Company,s lead compound. Results ... of anatabine citrate can significantly inhibit the activation of ... Company is developing this compound in a Phase 1 ...
Breaking Medicine Technology:Qiming Announces the Promotion of William Hu to Managing Partner 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4
... Pharmaceuticals, Inc. (Nasdaq: DUSA) announces that its ... will be issued on Friday, November 5th at 6:30 ... 8:30 a.m. Friday, November 5th - 8:30 a.m. E.D.T.If ... callers use:502-719-4466Password - DUSAA replay of the call will ...
... BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial -- CARMIEL, Israel, Nov. 2, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
Cached Medicine Technology:Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 2Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 3Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 4Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 5Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 6Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 7Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 8Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 9Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 10
(Date:7/2/2015)... ... July 02, 2015 , ... Evolved Ayurvedic Discoveries , ... an intention to partner with companies that share a similar mission of providing ... water soluble, Cannabidiol (CBD) formulations, combined with Ayurvedic herbs, are now available for ...
(Date:7/2/2015)... , ... July 02, 2015 , ... Today, East Liverpool ... the Surgical Center at East Liverpool City Hospital (ELCH). Pam is currently the Chief ... of the director of surgery. Pam holds a master’s degree in health care administration ...
(Date:7/2/2015)... ... ... As part of the celebration of its 70th anniversary, the Thantakit International ... all around the world for their continuous patronage of the world-class services of their ... (indeed, Thantakit is one of the foremost places for dental tourism in Thailand) or ...
(Date:7/2/2015)... ... , ... Maddock Douglas is an internationally recognized firm that ... manage the increasing demand for innovation as a primary growth strategy, Maddock Douglas ... , Benkendorf is a seasoned management executive with more than 25 years of ...
(Date:7/1/2015)... ... July 01, 2015 , ... Dr. ... Georgia State University and a Georgia Research Alliance Eminent Scholar in Inflammation and ... therapeutics against middle-ear infections. , The grant from the National Institute on Deafness ...
Breaking Medicine News(10 mins):Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 3Health News:Thailand's Longest Established International Dental Center Celebrates Its 70th Anniversary with Promos Galore 2Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2
... 15, 2007 The U.S. Pharmacopeia (USP) is ... dietary supplements for public notice and comment. ... Isoflavones monographs appeared in Pharmacopeial Forum (PF) 33(6), ... Turmeric, Powdered Turmeric, Powdered Turmeric Extract, Curcuminoids, Curcuminoids ...
... Nov. 15 Medical Services,International Inc. (Pink Sheets: MSITF) ... excellent independent test results obtained by regulatory,agencies related to ... the dual,VScan test kit that detects HIV and TB ... to be closely associated. It is very difficult to,get ...
... Launches Highly Accessible and ... Affordable Program ... YORK, Nov. 15 Chefs Diet(R), the leading meal,delivery service provider based ... My Solution -- a nationwide program that provides,chef-prepared, gourmet frozen meals for ...
... for Driver Safety Highlighted, WASHINGTON, Nov. 15 ... will hit the roads to spend time,with family and ... of the,11 million Americans with uncorrected vision problems. Depending ... could have,been eighteen years ago and some may never ...
... a study of more than 6,000 Los Angeles-area children ... Keck School of Medicine of the University of Southern California ... wall-eyed) and amblyopia (often referred to as lazy eye) were ... The study is currently available in the online edition of ...
... of men co-infected with herpes simplex virus type 2 (HSV-2) ... the levels of HIV in the blood and rectal secretions, ... This study is published in the November 15 issue ... , Most HIV-infected persons are also infected with HSV-2, ...
Cached Medicine News:Health News:USP announces 11 new proposed monographs for dietary supplements 2Health News:Medical Services Gets Significant Interest in Its Dual VScan Test Kit 2Health News:CHEFS DIET(R) Introduces My Solution 2Health News:Report Shows Millions May Be Driving with Uncorrected Visual Impairments 2Health News:Report Shows Millions May Be Driving with Uncorrected Visual Impairments 3Health News:USC study -- largest of its kind -- finds older children more likely to develop vision disorders 2Health News:Study shows suppressing herpes virus may reduce infectiousness of HIV 2
... PDA Closure Device has been developed for ... Arteriosus. Introduced through standard venous sheaths (10-14F) ... method for the percutaneous closure of persistent ... within the ductus.,An integral locking delivery and ...
Stainless steel plain Steinman Pins available in point types A through F....
Full pin skeletal traction pins with cove point....
Calibrated Guide Pins have a 12.7 mm calibration and are available in plain, with a threaded tip, or with a trocar point....
Medicine Products: